Peter McLaughlin

430 papers receiving 18.3k citations

Peter McLaughlin's Hit Papers

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project 2009 · 543 citations
5430+12+25Years since publication50010001.5k2.0k

Peers

Peter McLaughlin
Comparison fields: 5 of 197
  • Pathology and Forensic Medicine 10.8k
  • Genetics 4.9k
  • Oncology 6.4k
  • Neurology 2.2k
  • Hematology 1.6k
Replace Peter A. Jones with:
Peter A. Jones United States
Peter C. Nowell̀ United States
Avery A. Sandberg United States
Albert de la Chapelle Finland
Charis Eng United States
D.N. Cooper United Kingdom
Pier Giuseppe Pelicci Italy
George C. Ebers Canada
Shigeo Nakamura Japan
Charles Lee United States
Peter McLaughlin relative to Peter A. Jones United States Peter A. Jones's profile →
Citations per field
00.5×4.1×
Peter A. Jones · 1×
Citations per year

Countries citing papers authored by Peter McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Peter McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter McLaughlin more than expected).

Fields of papers citing papers by Peter McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter McLaughlin. The network helps show where Peter McLaughlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter McLaughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter McLaughlin Line = papers co-authored together Peter McLaughlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 442 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Hit paper breakdown →
19982249
2
Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment
Hit paper breakdown →
2000556
3
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Hit paper breakdown →
2009543
4
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)
Hit paper breakdown →
1988500
5 1998462
6 2004436
7 2005400
8 1994358
9 2001276
10 1998226
11 1996226
12 2008225
13 1987206
14 1984198
15 1993197
16 1992182
17 2003180
18 2010175
19
Interpolative background subtraction.
1976175
20 2008173

About Peter McLaughlin

Peter McLaughlin is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Molecular Biology, having authored 442 papers that have together received 19.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (237 papers), Chronic Lymphocytic Leukemia Research (96 papers), Viral-associated cancers and disorders (64 papers), CNS Lymphoma Diagnosis and Treatment (51 papers), Acute Lymphoblastic Leukemia research (17 papers), Cannabis and Cannabinoid Research (16 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). The work is most often cited by research in Pathology and Forensic Medicine (10.8k citations), Genetics (4.9k citations), Oncology (6.4k citations), Neurology (2.2k citations) and Hematology (1.6k citations). Peter McLaughlin has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Fernando Cabanillas, Fredrick B. Hagemeister, Jorge Romaguera, Maria Alma Rodriguez, Anas Younes, F Swan, Barbara Pro, A.J. Grillo-López, Luis Fayad and Christine A. White. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact